MSF urges govt to bring new US FDA approved TB drug bedaquiline to India to benefit MDR-TB patients
The Médecins Sans Frontières (MSF) has called upon the Union health ministry and the drug regulators in the country to work together to ensure that multi-drug resistant TB (MDR-TB) patients, who are left with few options, benefit from new TB drug bedaquiline, which has been approved by the US FDA for the first time since … Read more